Abraxis Pharmaceutical Products (APP) manufactures
and markets injectable pharmaceuticals for patients
facing life-threatening medical conditions. In the areas
of oncology, anti-infectives, and critical care, APP
markets more than 150 injectable products in more
than 400 dosage forms used in nearly every aspect
of care, including urgently needed but difficult to
manufacture products.